Citadel Advisors’s Scansource SCSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$541K Buy
14,900
+3,300
+28% +$126K ﹤0.01% 9110
2025
Q4
$453K Buy
+11,600
New +$479K ﹤0.01% 9267
2025
Q3
Sell
-5,800
Closed -$242K 13944
2025
Q2
$242K Sell
5,800
-1,900
-25% -$70.9K ﹤0.01% 10279
2025
Q1
$262K Buy
7,700
+6,400
+492% +$261K ﹤0.01% 9881
2024
Q4
$61.7K Buy
1,300
+600
+86% +$29.3K ﹤0.01% 12149
2024
Q3
$33.6K Sell
700
-1,400
-67% -$66.3K ﹤0.01% 12327
2024
Q2
$93.1K Buy
+2,100
New +$93.9K ﹤0.01% 11020
2023
Q4
Sell
-10,100
Closed -$306K 15130
2023
Q3
$306K Sell
10,100
-2,000
-17% -$60K ﹤0.01% 9131
2023
Q2
$358K Buy
12,100
+1,400
+13% +$40.5K ﹤0.01% 8658
2023
Q1
$326K Buy
10,700
+1,300
+14% +$40.4K ﹤0.01% 9205
2022
Q4
$275K Buy
+9,400
New +$279K ﹤0.01% 9509
2022
Q2
Sell
-14,600
Closed -$508K 13960
2022
Q1
$508K Sell
14,600
-2,300
-14% -$76K ﹤0.01% 9358
2021
Q4
$593K Buy
+16,900
New +$596K ﹤0.01% 9258

Other funds holding SCSC

Citadel Advisors's SCSC Position: Q1 2026 in Review

Citadel Advisors increased its Scansource (SCSC) stake by 100% in Q1 2026, buying an estimated $2.51M and bringing the position to 131,621 shares worth $4.78M. The position accounts for ﹤0.01% of the portfolio, ranked #4415.

Citadel Advisors first reported a position in SCSC in Q2 2013 and has held it in 43 quarters since. The position peaked at $17.6M in Q2 2025. 202 funds tracked by Wall St. Rank hold SCSC as of Q1 2026.

  • Citadel Advisors held 131,621 shares of Scansource worth $4.78M as of Q1 2026.
  • Citadel Advisors bought 65,729 Scansource shares in Q1 2026, an estimated $2.51M.
  • Scansource made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4415 holding.
  • Citadel Advisors first reported a position in Scansource in Q2 2013 and has held it in 43 quarters since.
  • Citadel Advisors's Scansource position peaked at $17.6M in Q2 2025.
  • 202 funds tracked by Wall St. Rank held Scansource as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.